Recursion Pharmaceuticals to present at Goldman Sachs Healthcare Conference on June 9, 2026

Recursion Pharmaceuticals, a clinical-stage TechBio company focused on drug discovery using AI, announced it will participate in the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. This event provides Recursion an opportunity to showcase its innovative AI-driven drug development platform and pipeline across oncology, rare diseases, neuroscience, and immunology. Investors and interested parties can access the webcast through the company's investor relations website. This participation highlights Recursion's ongoing efforts to advance medicines for unmet medical needs using cutting-edge technology.